BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRIW
Biofrontera Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.81−0.02 (-1.94%)
Close on Oct 19, 2026
- Market cap
- $10.41M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3M
Shares held, 13F filers
Institutional holders
19
9 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rosalind Master Fund L.P. | 9,886,969 | 9.90% | 13G (passive) amendment | Mar 31, 2025 |
| Orin Hirschman | 915,210 | 7.90% | 13G (passive) amendment | Dec 31, 2025 |
| AIGH Capital Management LLC | 884,563 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| The Hewlett Fund LP | 504,168 | 9.90% | 13G (passive) | Feb 22, 2024 |
| Alexander Link | 458,884 | 5.92% | 13D (active) amendment | Dec 20, 2024 |
| Delphi Unternehmensberatung Aktiengesellschaft | 2,552,230 | 19.99% | 13D (active) amendment | Sep 16, 2025 |
| Rosalind Advisors, Inc. | 16,801,629 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| Aharon Gil | 16,777,017 | 9.90% | 13G (passive) amendment | Oct 27, 2025 |
| Bigger Capital Fund, LP | 10,000 | – | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BFRI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 1,275,609 | – | $1.21M | +111,647 | 0.45% |
| AIGH Capital Management LLC | 739,910 | – | $699.59K | −175,300 | 0.04% |
| Renaissance Technologies LLC | 157,505 | – | $148.92K | New | 0.00% |
| Citadel Advisors LLC | 104,941 | – | $99.22K | New | 0.00% |
| Jane Street Group, LLC | 93,000 | – | $87.93K | New | 0.00% |
| Geode Capital Management, LLC | 76,689 | – | $72.51K | −32,611 | 0.00% |
| Vanguard Capital Management LLC | 71,380 | – | $67.53K | +19,126 | 0.00% |
| Vanguard Fiduciary Trust Co | 61,697 | – | $58.37K | – | 0.00% |
| XTX Topco Ltd | 51,894 | – | $49.07K | +29,401 | 0.00% |
| Hrt Financial LP | 43,349 | – | $40 | New | 0.00% |
| Northern Trust Corp | 31,536 | – | $29.82K | New | 0.00% |
| UBS Group AG | 18,518 | – | $17.52K | +16,978 | 0.00% |
| Sanctuary Advisors, LLC | 10,200 | – | $9.64K | – | 0.00% |
| Gsa Capital Partners Llp | 10,022 | – | $9 | New | 0.00% |
| Jones Financial Companies Lllp | 10,000 | – | $9.71K | New | 0.00% |
| BlackRock, Inc. | 4,622 | – | $4.37K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 332 | – | $314 | New | 0.00% |
| SBI Securities Co., Ltd. | 305 | – | $288 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | – | $1 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 3M | 9 / 4 | 2 / 2 | 1M | 0M |
| Q1 2026 | 12 | 2M | 2 / 7 | 1 / 3 | 0M | 0M |
| Q4 2025 | 14 | 2M | 3 / 4 | 4 / 2 | 0M | 0M |
| Q3 2025 | 13 | 2M | 5 / 5 | 2 / 2 | 0M | 0M |
| Q2 2025 | 10 | 2M | 2 / 6 | 1 / 4 | 1M | 0M |
| Q1 2025 | 12 | 1M | 3 / 3 | 5 / 5 | 0M | 0M |
| Q4 2024 | 14 | 2M | 5 / 6 | 1 / 0 | 1M | 0M |
| Q3 2024 | 9 | 1M | 1 / 0 | 5 / 3 | 0M | 0M |
| Q2 2024 | 12 | 1M | 4 / 3 | 0 / 3 | 0M | 0M |
| Q1 2024 | 11 | 1M | 6 / 0 | 2 / 3 | 1M | 0M |
| Q4 2023 | 8 | 0M | 3 / 2 | 0 / 2 | 0M | 0M |
| Q3 2023 | 7 | 0M | 7 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BFRI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 77,068 | – | $68.28K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 71,380 | – | $67.49K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 7,488 | – | $6.63K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 422 | – | $374 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Hermann Luebbert | CEO & Chairman, Director | 352,711 | Jul 29, 2026 |
| Eugene Frederick Leffler | Chief Financial Officer | 206,250 | Jul 29, 2026 |
| George Patrick Jones | Chief Commercial Officer | – | Mar 6, 2026 |
| Beth J. Hoffman | Director | – | Mar 6, 2026 |
| Kevin Daniel Weber | Director | – | Mar 6, 2026 |
| Heikki Lanckriet | Director | – | Mar 6, 2026 |
| John J. Borer Iii | Director | – | Mar 6, 2026 |
| la Huerta Martinez Maria del Pilar de | Director, 10% owner | 400,000 | Sep 25, 2025 |
| AG Biofrontera | Director, 10% owner | 400,000 | Sep 18, 2025 |
| Hansjoerg Plaggemars | 10% owner | – | Sep 30, 2025 |
| Beteiligungen Aktiengesellschaft VV | 10% owner | 458,884 | Sep 30, 2025 |
| Christian Alexander Ansgar Link | 10% owner | – | Sep 30, 2025 |
| Unternehmensberatung Aktiengesellschaft Delphi | 10% owner | 458,884 | Sep 30, 2025 |
| Balaton Aktiengesellschaft Deutsche | 10% owner | 458,884 | Sep 26, 2025 |
| Wilhelm Konrad Thomas Zours | 10% owner | 458,884 | Sep 26, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eugene Frederick Leffler Chief Financial Officer | Jul 28, 2026 | Option exercise | +31,250 | – | – | 206,250 |
| Hermann Luebbert CEO & Chairman, Director | Jul 28, 2026 | Option exercise | +62,500 | – | – | 352,711 |
| Eugene Frederick Leffler Chief Financial Officer | Mar 5, 2026 | Option exercise | +87,500 | – | – | 175,000 |
| Hermann Luebbert CEO & Chairman, Director | Mar 5, 2026 | Option exercise | +137,500 | – | – | 290,211 |
| Eugene Frederick Leffler Chief Financial Officer | Sep 10, 2025 | Option exercise | +87,500 | – | – | 87,500 |
| Hermann Luebbert CEO & Chairman, Director | Sep 10, 2025 | Option exercise | +137,500 | – | – | 152,711 |
| Hermann Luebbert CEO & Exec. Chairman, Director | May 18, 2024 | Option exercise | +4,771 | – | – | 15,211 |
| Erica L. Monaco Chief Executive Officer | May 18, 2023 | Option exercise | +76,336 | – | – | 133,025 |
| Hermann Luebbert Executive Chairman, Director | May 18, 2023 | Option exercise | +95,420 | – | – | 208,799 |
| Hermann Luebbert Executive Chairman, Director | Aug 22, 2022 | Option exercise | +113,379 | – | – | 113,379 |
| Erica L. Monaco Chief Executive Officer | Jul 1, 2022 | Option exercise | +56,689 | – | – | 56,689 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.